How can you increase your patient compliance?

• Around 35 to 50% of pharmaceutical patients are lost through drug non-compliance.
• You spend so much money attracting new patients, why lose them so quickly, especially for chronic conditions?
• How can you tell what programs will increase compliance for different brand?

Profile Your Brand

Compliance is a major issue for most chronic conditions. But although many programs can increase patient compliance, one size does not fit all. What works well with one of your brands may not work with another.
First, you need to profile the key factors affecting non-compliance for each brand, before deciding how to fix this. Various factors affect compliance including: the patients situation, the brands attributes, the therapeutic category issues, and marketplace events etc.
Knowing the key factors affecting your brand is a major step in successfully measuring the ROI of your brand.

Focus Your Analysis

Unfortunately, most compliance programs tend to be based more on how other brands have increased compliance, rather than focusing on the key factors affecting a specific brand.
Think ahead. Many pharmaceutical companies begin compliance programs without a strong understanding of how each program will influence the financial results of that brand.
Start by analyzing, evaluating and understanding your brand, before reviewing, planning and developing an appropriate compliance program.

Begin with 98.4 Patient Compliance Analytics

Manage your compliance program with Eularis 94.8 Patient Compliance Analytics. By using this advanced system a brand marketer can see exactly:
• Which factors are have an impact on the brand
• The size of that impact
• What needs to change to increase compliance by a specific amount.

Eularis 94.8 Analytics is a sophisticated system designed to effectively measure, evaluate and optimize brand performance and financial results. Because it focuses on current, not historical data, is one of todays most accurate pharmaceutical measuring tools.

Increase Your Compliance

Using Eularis 94.8 Patient Compliance Analytics, we carry out a series of comprehensive, proven steps, (listed below). These allow us to analyze, calculate, forecast and prove which specific patient compliance program will provide you with the most financial benefit for your brands market share:

Eularis proven steps for compliance programs:

• Understand the influence of compliance on the doctor initially prescribing your brand
• Calculate the impact of compliance for your individual brand
• Know which rational and emotional aspects are helping or hindering compliance
• Know which compliance programmes provide the most financial benefit to a brands market share
• Calculate the potential prescribing impact of specific individual compliance programmes, alone and against each other
• Know the optimal mix and budget of activities for maximum growth

In addition, this advanced activity requires a two staged process (Stage 1 with physicians and Stage 2 with patients) Uncover new growth opportunities and reduce the risks of a changing environment by building 94.8 Analytics into your patient compliance program process.

Why invest in 94.8 Analytics?

• Independent research showed an accuracy of 94.8% over several years
• The unique system pays for itself with a resulting rise in market share due to its accurate message focus and marketing mix allocation
• The system is continually updated to remain state of the art.

Ideal Users Of This System

• VP Sales and Marketing
• Sales and Marketing Directors
• Commercial Directors
• Business Unit Managers
• Business Analytics Managers
• Business Intelligence Managers
• Group Brand Managers
• Senior Product Managers
• Senior Brand Managers
• Agency Directors Needing to show ROI to their pharma brand clients

CONTACT US TODAY FOR ANY FURTHER INFORMATION ON ANY ASPECT OR TO SCHEDULE A MEETING FOR A DEMONSTRATION.